Effects of glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel: A meta-analysis of randomized trials

Keyphrases

• Confidence Interval 100%
• Randomized Trial 100%
• Meta-analysis 100%
• Odds Ratio 100%
• Clopidogrel 100%
• Glycoprotein IIb/IIIa Inhibitors 100%
• Percutaneous Coronary Intervention 100%
• Myocardial Infarction 50%
• Glycoprotein IIb-IIIa 50%
• Acute Coronary Syndrome 33%
• Heparin 33%
• Aspirin 33%
• Target Vessel Revascularization 33%
• MEDLINE 16%
• Loading Dose 16%
• Major Bleeding 16%
• Abciximab 16%
• Minor Bleeding 16%
• Electronic Search 16%
• Cochrane Central Register of Controlled Trials 16%
• Elective Percutaneous Coronary Intervention 16%

Neuroscience

• Meta-Analysis 100%
• Clopidogrel 100%
• Glycoprotein IIb/IIIa Inhibitors 100%
• Fibrinogen Receptor 75%
• Myocardial Infarction 75%
• Acute Coronary Syndrome 50%
• Heparin 50%
• Aspirin 50%
• Abciximab 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Fibrinogen Receptor 100%
• Clopidogrel 100%
• Heart Infarction 42%
• Acute Coronary Syndrome 28%
• Heparin 28%
• Acetylsalicylic Acid 28%
• Bleeding 14%
• Abciximab 14%